Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DRD”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Not applicableLooking for participantsNCT06497738
What this trial is testing

A Prospective Study Comparing DRd With VRd-lite in Elderly Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
The First Affiliated Hospital with Nanjing Medical University 112
Not applicableNot Yet RecruitingNCT07532473
What this trial is testing

REal World MAIA UK OutcomEs

Who this might be right for
Myeloma
The Royal Wolverhampton Hospitals NHS Trust 300
Not applicableStudy completedNCT00465790
What this trial is testing

Research of Biomarkers in Parkinson Disease

Who this might be right for
Parkinson DiseaseMultiple System AtrophyProgressive Supranuclear Palsy+3 more
Institut National de la Santé Et de la Recherche Médicale, France 219
Not applicableNot Yet RecruitingNCT07018271
What this trial is testing

A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaDRDSulpegfilgrastim+1 more
The First Affiliated Hospital of Soochow University 24
Not applicableUnknownNCT05713721
What this trial is testing

Sensorimotor Integration in Monogenic Parkinson-dystonia Syndromes

Who this might be right for
ParkinsonDystoniaDYT3+3 more
University Hospital Schleswig-Holstein 120
Large-scale testing (Phase 3)Looking for participantsNCT06679101
What this trial is testing

Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

Who this might be right for
Multiple MyelomaNewly Diagnosed Multiple Myeloma
GlaxoSmithKline 520
Large-scale testing (Phase 3)Looking for participantsNCT07665450
What this trial is testing

Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 1,000
Large-scale testing (Phase 3)Looking for participantsNCT05552222
What this trial is testing

Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 1,590
Large-scale testing (Phase 3)Looking for participantsNCT07095452
What this trial is testing

Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Who this might be right for
Multiple Myeloma
AbbVie 680
Not applicableStudy completedNCT05284591
What this trial is testing

Non-interventional Study to Evaluate Patient and Healthcare Provider Satisfaction of Daratumumab Use in the Treatment of First-line Daratumumab, Lenalidomide, Dexamethasone (DRd) Multiple Myeloma Patients in Germany Depending on Application Route (sc or iv)

Who this might be right for
Multiple MyelomaNewly DiagnosedTransplant Ineligible+3 more
iOMEDICO AG 96
Large-scale testing (Phase 3)Study completedNCT02076009
What this trial is testing

A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 569
Early research (Phase 1)Study completedNCT02918331
What this trial is testing

JNJ-54767414 (Daratumumab) in Combination With Lenalidomide and Dexamethasone in Japanese Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy and Autologous Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
Janssen Pharmaceutical K.K. 7
Not applicableLooking for participantsNCT03428009
What this trial is testing

Dystonia Genotype-Phenotype Correlation

Who this might be right for
DystoniaDystonia; IdiopathicDystonia, Primary+19 more
University of Texas Southwestern Medical Center 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04782687
What this trial is testing

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaMyeloma MultipleKahler Disease+4 more
US Oncology Research 73
Early research (Phase 1)Active Not RecruitingNCT06042725
What this trial is testing

MC210808 Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
Mayo Clinic 16
Large-scale testing (Phase 3)Study completedNCT02252172
What this trial is testing

Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 737